Gilsenan A, Andrews EB, Calingaert B, Crozier DA, Vanderpuije A. Evaluation of current risk evaluation and mitigation strategies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 16, 2009. Providence, RI.
Hansen RA, Song L, Moore CG, Gilsenan AW, Kim MM, Calloway MO, Murray MD. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials. Pharmacotherapy. 2009 Mar;29(3):255-62.
Leone P, Fleming DT, Gilsenan A, Li L, Justus S. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis. 2004 May 31;31(5):311-6.
Gilsenan A, Pedrazzani S, Bennett L, Li L, Yeager W, Haas JC. Observational prevalence study of HSV-2 (Genital Herpes) in suburban primary-care practices: data collection procedures and sampling methods. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 21, 2003.
Fleming D, Leone P, Gilsenan AW, Li L, Deeter R, Justus S. Seroprevalence of hsv-2 in suburban primary care offices. Poster presented at the ISSTDR Congress; 2003.
Justus S, Williams VS, Li L, Gilsenan AW, Fleeman K, Deeter R. African-American subgroup results from an hsv-2 seroprevalence study in suburban primary care physician offices. Poster presented at the ICAAC; 2003.